Literature DB >> 7553683

Expression of cytokine mRNA in human melanoma tissues.

E C Lattime1, M J Mastrangelo, O Bagasra, W Li, D Berd.   

Abstract

We have reported that patients with metastatic melanoma treated with an autologous, dinitrophenol-modified vaccine develop inflammatory responses at tumor sites. Histologically, these inflamed lesions are characterized by T cell infiltration, which is sometimes associated with tumor cell destruction. We tested biopsy specimens of eight subcutaneous metastases that had developed inflammation following vaccine treatment for expression of mRNA for interferon gamma (IFN gamma), interleukin-4 (IL-4), tumor necrosis factor alpha (TNF alpha), and IL-10. Post-vaccine, inflamed biopsies contained mRNA for IFN gamma (5/8), IL-4 (4/8) or both (3/8), and for TNF alpha (4/7). In contrast, IFN gamma mRNA was detected in only 1/17 and TNF alpha mRNA in 2/16 control specimens (pre-treatment lymph node metastases or non-inflamed subcutaneous metastases). mRNA for IL-10, a cytokine with anti-inflammatory properties, was detected in 24/25 melanoma metastases and was independent of lymphoid content; in situ the reverse transcriptase/polymerase chain reaction confirmed that melanoma cells were the major source. These findings may provide a new parameter by which to measure the effects of cancer immunotherapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7553683     DOI: 10.1007/bf01521340

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  20 in total

1.  Limiting dilution analysis of TNF producing cells in C3H/HeJ mice.

Authors:  E C Lattime; A Stoppacciaro; O Stutman
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

Review 2.  Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease.

Authors:  P Scott; E Pearce; A W Cheever; R L Coffman; A Sher
Journal:  Immunol Rev       Date:  1989-12       Impact factor: 12.988

3.  Investigation of cytokine gene expression in human colorectal cancer.

Authors:  M S Naylor; G W Stamp; F R Balkwill
Journal:  Cancer Res       Date:  1990-07-15       Impact factor: 12.701

4.  Tumor growth in vivo selects for resistance to tumor necrosis factor.

Authors:  E C Lattime; O Stutman
Journal:  J Immunol       Date:  1989-12-15       Impact factor: 5.422

5.  Changes in expression of CD45R during the development of Th1 and Th2 cell lines.

Authors:  W T Lee; E S Vitetta
Journal:  Eur J Immunol       Date:  1992-06       Impact factor: 5.532

6.  Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression.

Authors:  G A Gastl; J S Abrams; D M Nanus; R Oosterkamp; J Silver; F Liu; M Chen; A P Albino; N H Bander
Journal:  Int J Cancer       Date:  1993-08-19       Impact factor: 7.396

7.  Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma.

Authors:  Q Chen; V Daniel; D W Maher; P Hersey
Journal:  Int J Cancer       Date:  1994-03-01       Impact factor: 7.396

8.  Activation markers on T cells infiltrating melanoma metastases after therapy with dinitrophenyl-conjugated vaccine.

Authors:  D Berd; H C Maguire; M J Mastrangelo; G Murphy
Journal:  Cancer Immunol Immunother       Date:  1994-09       Impact factor: 6.968

9.  Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide.

Authors:  D Berd; H C Maguire; M J Mastrangelo
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

10.  IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.

Authors:  P Scott
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

View more
  11 in total

1.  Induction of 4-1BB (CD137) expression by DNA damaging agents in human T lymphocytes.

Authors:  Kwang-Mi Kim; Ho Won Kim; Jae-Ouk Kim; Kyoung-Min Baek; Joong Gon Kim; Chang-Yuil Kang
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

2.  Clonal expansion of T lymphocytes in human melanoma metastases after treatment with a hapten-modified autologous tumor vaccine.

Authors:  M Sensi; C Farina; C Maccalli; R Lupetti; G Nicolini; A Anichini; G Parmiani; D Berd
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

Review 3.  Immunosuppression in human tumor-host interaction: role of cytokines and alterations in signal-transducing molecules.

Authors:  R Kiessling; K Kono; M Petersson; K Wasserman
Journal:  Springer Semin Immunopathol       Date:  1996

4.  Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma.

Authors:  R Soiffer; T Lynch; M Mihm; K Jung; C Rhuda; J C Schmollinger; F S Hodi; L Liebster; P Lam; S Mentzer; S Singer; K K Tanabe; A B Cosimi; R Duda; A Sober; A Bhan; J Daley; D Neuberg; G Parry; J Rokovich; L Richards; J Drayer; A Berns; S Clift; L K Cohen; R C Mulligan; G Dranoff
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

5.  Low-dose-melphalan-induced up-regulation of type-1 cytokine expression in the s.c. tumor nodule of MOPC-315 tumor bearers and the role of interferon gamma in the therapeutic outcome.

Authors:  L Gorelik; M B Mokyr
Journal:  Cancer Immunol Immunother       Date:  1995-12       Impact factor: 6.968

6.  Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients.

Authors:  G Bellone; A Turletti; E Artusio; K Mareschi; A Carbone; D Tibaudi; A Robecchi; G Emanuelli; U Rodeck
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

7.  Bladder Cancer Immunotherapy: BCG and Beyond.

Authors:  Eric J Askeland; Mark R Newton; Michael A O'Donnell; Yi Luo
Journal:  Adv Urol       Date:  2012-06-20

Review 8.  The cancer stem cell: evidence for its origin as an injured autoreactive T cell.

Authors:  Peter Grandics
Journal:  Mol Cancer       Date:  2006-02-14       Impact factor: 27.401

9.  Recombinant Poxvirus and the Tumor Microenvironment: Oncolysis, Immune Regulation and Immunization.

Authors:  Daniel W Sharp; Edmund C Lattime
Journal:  Biomedicines       Date:  2016-08-12

10.  The influence of different culture microenvironments on the generation of dendritic cells from non-small-cell lung cancer patients.

Authors:  Paweł Krawczyk; Kamila Wojas; Janusz Milanowski; Jacek Roliński
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-12-03       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.